Table.
Actions before an outbreak | Actions during an outbreak | |
---|---|---|
Sequence, serotype, and share outbreak strain | Identify people and agencies, including local investigators, who will be expected to undertake this activity; ensure that MTAs, safe storage and transport, and fair allocation mechanisms for sharing specimens are in place; ensure mechanisms are in place for rapid release of funds to support the research | Sequence, serotype, and disseminate results; share outbreak strain with vaccine and animal model development teams |
Collect acute and convalescent blood samples and other body fluid specimens | Identify and fund investigators, including local investigators collaborating with front-line caregivers, who will collect and process specimens and maintain chain of custody; ensure specimen collection and handling is consistent with expected analytic needs; ensure that protocols, MTAs, and safe storage and transport (if needed) are in place; seek preapproval of protocol from ethics committee; ensure funding, supplies, and personnel are ready to begin when outbreak starts | Collect and transport or safely store specimens; if not done in advance with WHO, convene a scientific advisory committee to prioritise how samples should be interrogated and who they should be allocated to |
Accelerate development of diagnostic tests that can serve as endpoints for vaccine trials | Determine which diagnostic tests will likely be needed to support vaccine development, particularly tests that are different from those needed for outbreak detection and response; identify possible researchers and organisations who can develop these tests, and ensure protocols and agreements are in place, and that they have needed access to funds; collaborate with the specimen collection effort to ensure panels for test validation are rapidly assembled, and a process for allocating them is in place | Develop and validate diagnostic tests that will be needed for vaccine development; if relevant, ensure additional specimens are available for post outbreak validation and confirmation |
Do epidemiological studies essential for vaccine development | Identify and assess current surveillance systems and address key gaps relevant to vaccine development; ensure investigators who will work alongside outbreak response teams to collect data needed for vaccine development, trial design, and planning are trained and prepared; to the greatest extent possible, develop collection and testing protocols with investigators and public health authorities in advance of outbreak, and seek preapproval from the ethics committees; plan coordination between clinical trial teams and outbreak investigators, if a trial or vaccination effort is anticipated (eg, ring vaccination); ensure personnel, supplies, and rapidly available funding are in place | Collect and analyse epidemiological data (eg, seroprevalence, incidence, transmission dynamics, and geographical distribution) to support vaccine trial planning |
Understand cultures and beliefs | Identify behavioral and anthropological science team with relevant linguistic and cultural competencies; develop generic protocols for understanding knowledge, attitudes, beliefs in community, and seek preapproval of ethics committees; develop a just-in-time training package for local community members who will be involved in the work; ensure personnel, supplies, funding, and rapidly available funding are in place | Understand community beliefs regarding the disease, its control, and vaccination; provide community education through locally trained and trusted workforce |
MTA=material transfer agreement.